Industry News

Bayer MaterialScience Appoints Director, New Technologies and Strategic Initiatives, Future Business

Published on 2007-10-01. Author : SpecialChem

PITTSBURGH -- Bayer MaterialScience LLC (BMS) has named John Brandt the Director of New Technologies and Strategic Initiatives in the Future Business group. In this position, Brandt will be charged with identifying business opportunities both within and outside the BMS traditional business structure.

Brandt joined the Bayer organization in 1988 as a chemist in the Coatings Division and moved up through the company in various positions of increasing responsibility, including serving as the head of marketing and sealants for the EMEA region in Germany.

Upon his return to the United States in 2005, Brandt was responsible for BMS Greenhouse and GENESIS activities in the NAFTA region - two initiatives designed to foster the kind of entrepreneurial environment where innovation thrives and ultimately translates into business opportunities - and provided support to the Bayer Strategic Science Education Reform initiatives.

Bayer MaterialScience LLC is one of the leading producers of polymers and high-performance plastics in North America and is part of the global Bayer MaterialScience business with nearly 14,900 employees at 30 sites around the world and 2006 sales of 10.2 billion euros from continuing operations. Our innovative developments in coatings, adhesive and sealant raw materials, polycarbonates, polyurethanes and thermoplastic urethane elastomers enhance the design and functionality of products in a wide variety of markets, including the automotive, construction, electrical and electronics, household and medical industries, and the sports and leisure fields. Our inorganic basic chemicals unit produces chlorine and related essential products for the chemicals industry. Let us give life to your vision.

Bayer Corporation, headquartered in Pittsburgh, is a subsidiary of Bayer AG, an international health care, nutrition and innovative materials group based in Leverkusen, Germany. In North America, Bayer had 2006 net sales of 7.8 billion euros and employed 17,200 at year end. Bayer's three subgroups, Bayer HealthCare, Bayer CropScience and Bayer MaterialScience, improve people's lives through a broad range of essential products that help diagnose, prevent and treat diseases; protect crops and enhance yields; and advance automobile safety and durability. Bayer AG stock is a component of the DAX and is listed on the New York Stock Exchange.

This news release contains forward-looking statements based on current assumptions and forecasts made by Bayer Group management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. Th ese factors include those discussed in our public reports filed with the Frankfurt Stock Exchange and with the U.S. Securities and Exchange Commission (including our Form 20-F). The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

Source: Bayer MaterialScience

Sustainnovation is not a buzzword
Channel Alerts

Receive weekly digests on hot topics

Back to Top